SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity.
Liu H, Ertay A, Peng P, Li J, Liu D, Xiong H, Zou Y, Qiu H, Hancock D, Yuan X, Huang WC, Ewing RM, Downward J, Wang Y.
Liu H, et al. Among authors: huang wc.
Mol Oncol. 2019 Sep;13(9):1874-1886. doi: 10.1002/1878-0261.12530. Epub 2019 Jun 14.
Mol Oncol. 2019.
PMID: 31199048
Free PMC article.